443 related articles for article (PubMed ID: 27163705)
1. Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections.
Bächle SM; Malone DF; Buggert M; Karlsson AC; Isberg PE; Biague AJ; Norrgren H; Medstrand P; Moll M; Sandberg JK; Jansson M;
AIDS; 2016 Jul; 30(11):1713-22. PubMed ID: 27163705
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.
Buggert M; Frederiksen J; Lund O; Betts MR; Biague A; Nielsen M; Tauriainen J; Norrgren H; Medstrand P; Karlsson AC; Jansson M;
AIDS; 2016 Oct; 30(16):2415-2426. PubMed ID: 27525551
[TBL] [Abstract][Full Text] [Related]
3. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
4. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
[TBL] [Abstract][Full Text] [Related]
5. Functional Invariant Natural Killer T Cells Secreting Cytokines Are Associated With Non-Progressive Human Immunodeficiency Virus-1 Infection but Not With Suppressive Anti-Retroviral Treatment.
Singh D; Ghate M; Godbole S; Kulkarni S; Thakar M
Front Immunol; 2018; 9():1152. PubMed ID: 29881390
[TBL] [Abstract][Full Text] [Related]
6. Activation of NK cells is associated with HIV-1 disease progression.
Kuri-Cervantes L; de Oca GS; Avila-Ríos S; Hernández-Juan R; Reyes-Terán G
J Leukoc Biol; 2014 Jul; 96(1):7-16. PubMed ID: 24399837
[TBL] [Abstract][Full Text] [Related]
7. Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.
Luo Z; Li Z; Martin L; Hu Z; Wu H; Wan Z; Kilby M; Heath SL; Huang L; Jiang W
PLoS One; 2017; 12(1):e0167640. PubMed ID: 28076376
[TBL] [Abstract][Full Text] [Related]
8. Immune signatures for HIV-1 and HIV-2 induced CD4
Salwe S; Singh A; Padwal V; Velhal S; Nagar V; Patil P; Deshpande A; Patel V
BMC Infect Dis; 2019 Feb; 19(1):135. PubMed ID: 30744575
[TBL] [Abstract][Full Text] [Related]
9. Immunologic features of HIV-1-infected women on HAART at delivery.
Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.
Nuvor SV; van der Sande M; Rowland-Jones S; Whittle H; Jaye A
J Virol; 2006 Mar; 80(5):2529-38. PubMed ID: 16474159
[TBL] [Abstract][Full Text] [Related]
11. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
[TBL] [Abstract][Full Text] [Related]
12. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
13. Th1 and Th17 proinflammatory profile characterizes invariant natural killer T cells in virologically suppressed HIV+ patients with low CD4+/CD8+ ratio.
De Biasi S; Bianchini E; Nasi M; Digaetano M; Gibellini L; Carnevale G; Borghi V; Guaraldi G; Pinti M; Mussini C; Cossarizza A
AIDS; 2016 Nov; 30(17):2599-2610. PubMed ID: 27782963
[TBL] [Abstract][Full Text] [Related]
14. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
[TBL] [Abstract][Full Text] [Related]
15. Immune Dysfunctions of CD56
Cao WJ; Zhang XC; Wan LY; Li QY; Mu XY; Guo AL; Zhou MJ; Shen LL; Zhang C; Fan X; Jiao YM; Xu RN; Zhou CB; Yuan JH; Wang SQ; Wang FS; Song JW
Front Immunol; 2021; 12():811091. PubMed ID: 35069597
[TBL] [Abstract][Full Text] [Related]
16. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype.
Montoya CJ; Cataño JC; Ramirez Z; Rugeles MT; Wilson SB; Landay AL
Clin Immunol; 2008 Apr; 127(1):1-6. PubMed ID: 18304877
[TBL] [Abstract][Full Text] [Related]
17. Polyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects.
Lima JF; Oliveira LMS; Pereira NZ; Duarte AJS; Sato MN
Sci Rep; 2017 Apr; 7(1):524. PubMed ID: 28373665
[TBL] [Abstract][Full Text] [Related]
18. Memory and naive-like regulatory CD4+ T cells expand during HIV-2 infection in direct association with CD4+ T-cell depletion irrespectively of viremia.
Foxall RB; Albuquerque AS; Soares RS; Baptista AP; Cavaleiro R; Tendeiro R; Gomes P; Victorino RM; Sousa AE
AIDS; 2011 Oct; 25(16):1961-70. PubMed ID: 21811143
[TBL] [Abstract][Full Text] [Related]
19. Elevated CD54 Expression Renders CD4+ T Cells Susceptible to Natural Killer Cell-Mediated Killing.
Chen X; Chen H; Zhang Z; Fu Y; Han X; Zhang Y; Xu J; Ding H; Cui H; Dong T; Shang H; Jiang Y
J Infect Dis; 2019 Nov; 220(12):1892-1903. PubMed ID: 31433832
[TBL] [Abstract][Full Text] [Related]
20. T-cell and B-cell perturbations are similar in ART-naive HIV-1 and HIV-1/2 dually infected patients.
Hønge BL; Petersen MS; Jespersen S; Medina C; Té DDS; Kjerulff B; Jensen MM; Steiniche D; Esbjörnsson J; Laursen AL; Wejse C; Krarup H; Møller BK; Erikstrup C;
AIDS; 2019 Jun; 33(7):1143-1153. PubMed ID: 30845069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
